Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 104 pseudogene (RNU7-104P) is a processed pseudogene related to the U7 small nuclear RNA gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations. While functional U7 snRNA is essential in the 3'-end processing of replication-dependent histone pre-mRNAs, this pseudogene does not participate in that pathway[1][5]. Like other processed pseudogenes, RNU7-104P may be transcribed at low levels but is not known to be translated into protein, nor does it have any reported role in cellular function, disease, or as a therapeutic target[4][5][6]. There are no drugs, mechanisms of action, biomarkers, or safety/therapeutic concerns associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 104 pseudogene (RNU7-104P).